Sleep Apnea in HGV Drivers: EU Directive 2014/85/EU Rules and Treatment Options 2026

Sleep apnea is a licence-critical condition for European HGV drivers. EU Directive 2014/85/EU explicitly states that moderate or severe obstructive sleep apnea combined with excessive daytime sleepiness is incompatible with Group 2 driving unless controlled by treatment with adequate compliance. Each member state implements this rule slightly differently, but failure to disclose can mean licence suspension, fines, and in serious crashes, criminal charges. Read more about how the airway problem works in our guide on obstructive sleep apnea explained.

This article walks you through the EU directive, the national rules in Germany, France, the United Kingdom, Spain, Italy, and the Netherlands, and the practical treatment pathway HGV drivers actually follow in 2026. We also cover affordable bridge options like nasal stents to reduce snoring and screen risk while waiting for diagnosis. For deeper context read our overview on sleep apnea symptoms and treatments.

What EU Directive 2014/85/EU actually says

Directive 2014/85/EU, which amended Annex III of Directive 2006/126/EC on driving licences, was the first EU instrument to set explicit rules on sleep apnea. It applies to all 27 member states, plus the United Kingdom in equivalent post-Brexit form. The directive creates two main categories.

"Adequate compliance" usually means a sleep specialist's report showing AHI below 5 to 10 on therapy, typically with at least 4 hours per night of CPAP use, or equivalent benefit from a mandibular advancement device or hypoglossal implant. Reviews are required every 1 to 3 years for Group 2 (HGV, bus) licences and at least every 3 years for Group 1.

National implementation across major EU markets

Germany — Fahrerlaubnis-Verordnung (FeV)

The Fahrerlaubnis-Verordnung (FeV) and the related Begutachtungsleitlinien require Group 2 drivers with diagnosed moderate-to-severe OSA to provide a sleep specialist report confirming AHI control and CPAP adherence above 70 percent of nights. The Kraftfahrt-Bundesamt (KBA) coordinates nationally, with assessments done by certified Begutachtungsstellen.

France — Code de la route Article R.221-19

Article R.221-19 references the medical fitness annex (arrêté du 28 mars 2022). HGV drivers must declare moderate-to-severe OSA. The licence is suspended until treatment is confirmed effective by a sleep specialist (preuve de compliance via CPAP usage data). National road safety body for incidents: ANTAI for sanctions, with préfecture handling the licence file.

United Kingdom — DVLA Group 2

The Driver and Vehicle Licensing Agency (DVLA) treats Group 2 (LGV / PCV) very strictly. Drivers must notify DVLA when OSA is diagnosed. Driving must stop immediately if there is excessive sleepiness. Group 2 licences are reissued after a sleep specialist confirms adequate control, typically reviewed every 1 to 3 years.

Spain — Reglamento General de Conductores

The Reglamento General de Conductores (Real Decreto 818/2009) lists OSA among reportable conditions. The Centro de Reconocimiento Médico de Conductores reviews each renewal. Compliance is documented through the prescribing sleep unit.

Italy — Codice della Strada

The Codice della Strada and the 2018 ministerial decree on patenti require pneumology / sleep specialist clearance for HGV drivers with diagnosed OSA. CPAP adherence reports from the device memory card are part of the file.

Netherlands — CBR (Centraal Bureau Rijvaardigheidsbewijzen)

The CBR requires Group 2 drivers to declare OSA. The Eigen verklaring health declaration triggers a specialist review. Without proven treatment compliance, licence suspension applies until therapy is confirmed effective.

Why HGV drivers are at higher risk for OSA

EU and ETSC (European Transport Safety Council) data suggest 15 to 20 percent of professional drivers have undiagnosed obstructive sleep apnea. Risk factors stack on this group: long sedentary hours, irregular sleep schedules, higher BMI, larger neck circumference, and frequent alcohol exposure during off-duty rest. Untreated OSA raises crash risk roughly 7-fold compared with healthy drivers, according to a 2017 European Sleep Research Society review.

Snoring is the most visible early sign. If your bed partner reports loud nightly snoring or you fall asleep at rest stops, treat it as a medical priority, not a minor nuisance. Read more about link between snoring and sleep apnea for context.

Treatment pathway HGV drivers actually follow in 2026

Step 1. Risk screening at the next medical exam

HGV medical examinations include the STOP-BANG questionnaire in most EU countries since 2018. A score of 3 or more triggers a referral to a sleep specialist. You can self-screen between exams using the same tool.

Step 2. Home sleep test or polysomnography

EU sleep clinics deliver home sleep tests within 4 to 12 weeks in most regions, fully or largely reimbursed by Sécurité Sociale, GKV, NHS, SSN, INAMI, or Zorgverzekering for suspected OSA. The result delivers your AHI.

Step 3. Treatment selection

For moderate-to-severe OSA with daytime sleepiness, CPAP is the first-line therapy and is reimbursed in every major EU system for diagnosed Group 2 drivers. For mild-to-moderate OSA, a custom mandibular advancement device or hypoglossal nerve implant (Inspire or Nyxoah Genio) may be approved. For snoring while awaiting full assessment, low-cost nasal stents can reduce nightly noise and improve sleep, but they do not replace formal CPAP adherence for licence purposes.

Step 4. Compliance documentation

For licence renewal, the sleep specialist provides a compliance report drawn from CPAP machine data: average nightly use above 4 hours, residual AHI below 5, and reduced Epworth Sleepiness Scale score. Equivalent reports exist for MAD and implant users.

Step 5. Periodic re-evaluation

Every 1 to 3 years, depending on country, you renew the medical certificate with an updated specialist report. Most drivers maintain their Group 2 licence indefinitely once compliance is established.

Affordable bridge options while you wait for diagnosis

Sleep clinic wait times for HGV drivers are shorter than civilian queues but can still run 4 to 12 weeks. While you wait, you can act on the snoring component immediately. None of the bridge tools below replaces a full diagnosis, but they reduce nightly disturbance and partner exposure. Keep all CPAP-related decisions for the sleep specialist.

What happens if you fail compliance

If a sleep specialist reports inadequate compliance (CPAP use under 4 hours per night, AHI not controlled, ongoing daytime sleepiness), the licensing authority will suspend Group 2 driving until therapy is reset. Common reasons include mask intolerance, nasal congestion, partner intolerance, or poorly fitting equipment.

The fix is usually mechanical: better mask fit, treating nasal congestion, switching to a mandibular advancement device, or in selected cases moving to an Inspire or Nyxoah Genio implant. Many drivers pair their CPAP with nasal aids to reduce mask leak and improve adherence.

Frequently asked questions